Van Eck Associates Corp Eli Lilly & CO Transaction History

Van Eck Associates Corp

$80.1 Billion
Q3 2024

A detailed history of Van Eck Associates Corp transactions in Eli Lilly & CO stock. As of the latest transaction made, Van Eck Associates Corp holds 269,469 shares of LLY stock, worth $216 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares

269,469

Previous 241,004 11.81%

Holding current value

$216 Million

Previous $218 Million 11.55%

% of portfolio

0.3%

Previous 0.31%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	BUY	$772.14 - $960.02 $22 Million - $27.3 Million	28,465 Added 11.81%	269,469 $243 Million
Q2 2024 Jul 31, 2024	SELL	$724.87 - $909.04 $3.1 Million - $3.89 Million	-4,283 Reduced 1.75%	241,004 $218 Million
Q1 2024 Apr 30, 2024	BUY	$592.2 - $792.28 $13.8 Million - $18.4 Million	23,286 Added 10.49%	245,287 $191 Million
Q4 2023 Feb 05, 2024	BUY	$525.19 - $619.13 $6.54 Million - $7.71 Million	12,447 Added 5.94%	222,001 $129 Million
Q3 2023 Nov 08, 2023	BUY	$434.7 - $599.3 $10.4 Million - $14.4 Million	23,950 Added 12.9%	209,554 $113 Million
Q2 2023 Aug 03, 2023	SELL	$350.74 - $468.98 $76,461 - $102,237	-218 Reduced 0.12%	185,604 $87 Million
Q1 2023 May 03, 2023	SELL	$310.63 - $364.82 $7.88 Million - $9.25 Million	-25,360 Reduced 12.01%	185,822 $63.8 Million
Q4 2022 Feb 08, 2023	SELL	$321.55 - $374.67 $1.96 Million - $2.28 Million	-6,091 Reduced 2.8%	211,182 $77.3 Million
Q3 2022 Oct 27, 2022	BUY	$296.48 - $337.87 $1.71 Million - $1.95 Million	5,781 Added 2.73%	217,273 $70.3 Million
Q2 2022 Aug 03, 2022	BUY	$278.73 - $327.27 $11.9 Million - $14 Million	42,793 Added 25.37%	211,492 $68.6 Million
Q1 2022 May 10, 2022	BUY	$234.69 - $291.66 $439,104 - $545,695	1,871 Added 1.12%	168,699 $48.3 Million
Q4 2021 Jan 26, 2022	BUY	$224.85 - $279.04 $4.26 Million - $5.29 Million	18,958 Added 12.82%	166,828 $46.1 Million
Q3 2021 Nov 03, 2021	BUY	$221.6 - $272.71 $3.65 Million - $4.49 Million	16,456 Added 12.52%	147,870 $34.2 Million
Q2 2021 Aug 10, 2021	BUY	$180.55 - $233.54 $11 Million - $14.2 Million	60,930 Added 86.45%	131,414 $30.2 Million
Q1 2021 May 13, 2021	SELL	$164.32 - $212.72 $3.8 Million - $4.92 Million	-23,116 Reduced 24.7%	70,484 $13.2 Million
Q4 2020 Feb 09, 2021	BUY	$130.46 - $172.63 $556,542 - $736,439	4,266 Added 4.78%	93,600 $15.8 Million
Q3 2020 Nov 12, 2020	SELL	$146.22 - $169.13 $2.03 Million - $2.35 Million	-13,891 Reduced 13.46%	89,334 $13.2 Million
Q2 2020 Aug 10, 2020	SELL	$136.42 - $164.18 $5.99 Million - $7.21 Million	-43,942 Reduced 29.86%	103,225 $16.9 Million
Q1 2020 May 12, 2020	SELL	$119.05 - $147.35 $2.12 Million - $2.62 Million	-17,809 Reduced 10.79%	147,167 $20.4 Million
Q4 2019 Feb 13, 2020	BUY	$106.92 - $132.43 $5.86 Million - $7.26 Million	54,817 Added 49.76%	164,976 $21.7 Million
Q3 2019 Nov 08, 2019	SELL	$106.79 - $116.16 $611,693 - $665,364	-5,728 Reduced 4.94%	110,159 $12.3 Million
Q2 2019 Aug 07, 2019	BUY	$110.79 - $129.32 $497,890 - $581,164	4,494 Added 4.03%	115,887 $12.8 Million
Q1 2019 May 13, 2019	SELL	$111.31 - $131.02 $6.7 Million - $7.89 Million	-60,224 Reduced 35.09%	111,393 $14.5 Million
Q4 2018 Feb 12, 2019	SELL	$105.9 - $118.64 $23.6 Million - $26.4 Million	-222,536 Reduced 56.46%	171,617 $19.9 Million
Q3 2018 Nov 13, 2018	SELL	$85.86 - $107.31 $20.9 Million - $26.1 Million	-243,556 Reduced 38.19%	394,153 $42.3 Million
Q2 2018 Aug 13, 2018	BUY	$75.7 - $86.88 $3.8 Million - $4.36 Million	50,207 Added 8.55%	637,709 $54.4 Million
Q1 2018 May 11, 2018	BUY	$74.21 - $87.6 $4.27 Million - $5.04 Million	57,487 Added 10.85%	587,502 $45.5 Million
Q4 2017 Feb 12, 2018	SELL	$81.94 - $87.89 $1.39 Million - $1.49 Million	-16,953 Reduced 3.1%	530,015 $44.8 Million
Q3 2017 Nov 09, 2017	BUY	$77.07 - $85.54 $1.69 Million - $1.88 Million	21,939 Added 4.18%	546,968 $46.8 Million
Q2 2017 Aug 11, 2017	BUY	N/A	525,029	525,029 $43.2 Million

Others Institutions Holding LLY

# of Institutions

4,016

Shares Held

739M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $760B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Van Eck Associates Corp, based on Form 13F filings with the SEC.

News

Stay updated on Van Eck Associates Corp with notifications on news.

Account

Van Eck Associates Corp Eli Lilly & CO Transaction History